Anti-Heart Failure Agent 1 is an orally available compound used for the study of heart failure without inducing nausea, vomiting, or agitation; it significantly enhances left ventricular contractility in vivo (e.g., 60% increase at 15 mg/kg in anesthetized cats and 45% increase at 25 mg/kg orally in conscious dogs).